Spero Therapeutics Q3 EPS $(0.76) Misses $(0.47) Estimate
Benzinga Newsdesk 1 week ago
NewsEarningsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Spero Therapeutics (NASDAQ:SPRO) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.47) by 61.7 percent. This is a 484.62 percent decrease over losses of $(0.13) per share
Spero Therapeutics (NASDAQ:SPRO) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.47) by 61.7 percent. This is a 484.62 percent decrease over losses of $(0.13) per share from the same period last year.
